These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9088026)

  • 1. Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins.
    Takano Y; Saegusa M; Ikenaga M; Okayasu I
    Pathol Int; 1997; 47(2-3):90-4. PubMed ID: 9088026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr-virus-positive non-Hodgkin's lymphomas.
    Takano Y; Saegusa M; Masuda M; Mikami T; Okayasu I
    J Cancer Res Clin Oncol; 1997; 123(7):395-401. PubMed ID: 9260592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53.
    Soini Y; Raunio H; Pääkkö P
    Tumour Biol; 1998; 19(3):176-85. PubMed ID: 9591044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
    Korkolopoulou P; Oates J; Kittas C; Crocker J
    J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma.
    Miracco C; Santopietro R; Biagioli M; Lazzi S; Nyongo A; Vatti R; Luzi P
    J Cutan Pathol; 1998 May; 25(5):244-51. PubMed ID: 9696289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.
    Leoncini L; Del Vecchio MT; Megha T; Barbini P; Galieni P; Pileri S; Sabattini E; Gherlinzoni F; Tosi P; Kraft R
    Am J Pathol; 1993 Mar; 142(3):755-63. PubMed ID: 7681257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
    Yin H; Okada N; Takagi M
    J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma.
    Gisbertz IA; Schouten HC; Bot FJ; Arends JW
    Histopathology; 1997 Feb; 30(2):152-9. PubMed ID: 9067740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
    Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
    Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL).
    Palestro G; Ponti R; Chiusa L; Chiarle R; Geuna M; Novero D; Freilone R; Pich A
    Eur J Haematol; 1997 Sep; 59(3):148-54. PubMed ID: 9310122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB; Papadimitriou JC; Drachenberg CB
    Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma.
    Pătraşcu AM; Rotaru I; Olar L; Pătraşcu Ş; Ghiluşi MC; NeamŢu SD; Nacea JG; Gluhovschi A
    Rom J Morphol Embryol; 2017; 58(3):837-843. PubMed ID: 29250662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of apoptotic cell death in non-Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression.
    Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsenga A; Patsouris E; Thomas-Tsagli E; Kittas C; Pangalis GA
    Histopathology; 1998 Sep; 33(3):240-7. PubMed ID: 9777390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth patterns of diffuse non-Hodgkin's lymphomas estimated from mitotic and apoptotic indices.
    Spina D; Leoncini L; Megha T; Gallorini M; Tosi P; Pileri S; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1997 Oct; 73(2):178-83. PubMed ID: 9335438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
    Abdulla M; Laszlo S; Triumf J; Hedström G; Berglund M; Enblad G; Amini RM
    Acta Oncol; 2016; 55(9-10):1126-1131. PubMed ID: 27549735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dolastatin 10 on human non-Hodgkin's lymphoma cell lines.
    Maki A; Mohammad R; Raza S; Saleh M; Govindaraju KD; Pettit GR; al-Katib A
    Anticancer Drugs; 1996 May; 7(3):344-50. PubMed ID: 8792010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.